Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > QA & LT

QA & LT

Drug Product Recall: Nyloz Capsule (Batch # C01358) by M/s Zephyr Pharmatec, Karachi and marketed By S.J & G. Fazul Ellahie, Karachi

Murtaza Awan Recall Alerts August 9, 2021February 23, 2022QA & LT

Nyloz Capsule, Batch No. C01358 Manufactured By M/S Zephyr Pharmatec, Karachi & Marketed By S.J & G. Fazul Ellahie, Karachi

PDF FileDownload

Drug Product Recall: Meronem Injection (Batch # 4B20E273) by M/s Pfizer Pakistan Limited, Karachi

Murtaza Awan Recall Alerts August 2, 2021February 23, 2022QA & LT

Meronem Injection, Batch No. 4B20E273 Purpoted To Be Manufactured By M/S Pfizer Pakistan Limited

PDF FileDownload

Drug Product Recall: Indobid Capsules (Batch # 386) by M/s Adamjee Pharmaceuticals (Pvt),Ltd Karachi.

Murtaza Awan Recall Alerts July 15, 2021February 23, 2022QA & LT

Indobid Capsules,Reg No.007106,Batch No.386 Manufactured By M/S Adamjee Pharmaceuticals (Pvt),Ltd Karachi.

PDF File Download

Drug Product Recall: Parapals Infusion (Batch # LI-051) by M/s Inventor Pharma Karachi

Murtaza Awan Recall Alerts July 13, 2021February 23, 2022QA & LT

Parapals Infusion,Reg. No. 088360. Batch No. LI-051. Manufactured By M/S Inventor Pharma Karachi

PDF FileDownload

Drug Product Recall: Parapals Infusion (Batch#LI-052) By M/S Inventor Pharma Karachi

Murtaza Awan Recall Alerts July 13, 2021February 23, 2022QA & LT

Parapals Infusion,Reg. No. 088360. Batch No. LI-052. Manufactured By M/S Inventor Pharma Karachi

PDF FileDownload

Drug Product Recall: Tempramine Suspension (Batch # 5TE049) By M/s W.Woodward Pakistan (Pvt.) Ltd., Karachi

Murtaza Awan Recall Alerts July 9, 2021February 23, 2022QA & LT

Tempramine Suspension. Reg. No.011432 Batch No. 5TE049 Manufactured By M/S W.Woodward Pakistan (Pvt.) Ltd., Karachi

Tempramine-susp-4Download

Drug Product Recall: Tempramine Suspension (Batch# 5TR052) By M/S W.Woodward Pakistan (Pvt.) Ltd., Karachi.

Murtaza Awan Recall Alerts July 9, 2021February 23, 2022QA & LT

Tempramine Suspension. Reg. No.011432 Batch No. 5TR052 Manufactured By M/S W.Woodward Pakistan (Pvt.) Ltd.,Karachi.

PDF FileDownload

Drug Product Recall: Tempramine Suspension (Batch # 5TR131) By M/S W. Woodward Pakistan (Pvt.) Ltd., Karachi.

Murtaza Awan Recall Alerts July 9, 2021February 23, 2022QA & LT

Tempramine Suspension. Reg. No.011432 Batch No. 5TR131 Manufactured By M/S W.Woodward Pakistan (Pvt.) Ltd.,Karachi.

Tempramin-susp-2Download

Drug Product Recall: Tempramine Suspension (Batch#5TR057) By M/S W.Woodward Pakistan (Pvt.) Ltd., Karachi.

Murtaza Awan Recall Alerts July 9, 2021February 23, 2022QA & LT

Tempramine Suspension. Reg. No.011432 Batch No 5TR057 Manufactured By M/S W.Woodward Pakistan (Pvt.) Ltd., Karachi.

PDF FileDownload
  • Next →

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • November 2017
  • October 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • November 2016
  • June 2016
  • March 2016
  • May 2014
  • March 2014
  • January 2014
  • October 2013
  • August 2013
  • April 2013
  • October 2012
  • July 2012
  • March 2012
  • February 2002

Meta

  • Log in

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem